Sort
40,608 grants matching “prostate cancer”
Defining Molecular Determinants of Lineage Plasticity as a Mechanism of Treatment Resistance in Prostate Cancer
$462,840David S. Rickman · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Tissue/Informatics
$462,806Lakshmi Priya Kunju · University Of Michigan At Ann Arbor · P50 · FY2017 · CA
Molecular Epidemiology of Prostate Cancer in Tobagonians
$462,777Clareann H. Bunker · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · CA
Probe Optimization for Prostate Cancer Detection
$462,741Clifford Berkman · Washington State University · R01 · FY2011 · CA
Mechanisms that Couple Chromatin Modifications to Transcription
$462,740Karen M Arndt · University Of Pittsburgh At Pittsburgh · R35 · FY2023 · GM
Mechanisms that Couple Chromatin Modifications to Transcription
$462,740Karen M Arndt · University Of Pittsburgh At Pittsburgh · R35 · FY2025 · GM
Mechanisms that Couple Chromatin Modifications to Transcription
$462,740Karen M Arndt · University Of Pittsburgh At Pittsburgh · R35 · FY2024 · GM
HOMING PEPTIDES FOR THE VASCULATURE IN PROSTATE
$462,715Erkki I Ruoslahti · Sidney Kimmel Cancer Center · P01 · FY2008 · CA
Targeting ferroptosis in aggressive subtypes of lung cancer
$462,704Triparna Sen · Ohio State University · R01 · FY2025 · CA
Microendoscopic Electrical Impedance Sensing for Real-time Intraoperative Surgical Margin Assessment
$462,685Ryan Joseph Halter · Dartmouth College · R01 · FY2024 · CA
Computer Support for Prostate Cancer Screening in the PLCO Cancer Screening Trial
$462,641William Lake · Information Management Services, Inc. · N02 · FY2012 · CA
Regulation of Mitochondrial Metabolism by Tyr-phosphorylated ATP Synthase Alpha-Subunit and its Therapeutic Implications in Prostate Cancer
$462,560Nupam P Mahajan · Washington University · R01 · FY2025 · CA
Defining the Role of ERG in Modulating the AR Cistrome and Antiandrogen Sensitivity
$462,551Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Support for the Central Data Collection Center (CDCC)
$462,520Sunitha Mathew · Westat, Inc. · N02 · FY2025 · CA
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer
$462,518Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2017 · CA
REGULATORY MECHANISM OF NONCANONICAL HEDGEHOG SIGNALING AND ITS ASSOCIATION WITH AUTOPHAGY IN CASTRATION-RESISTANT PROSTATE CANCER.
$462,500Board Of Regents Of The University Of Nebraska · · FY2021 · Defense Health Agency
Multidisciplinary Training in Image Guided Therapy
$462,452Fiona Fennessy · Brigham And Women'S Hospital · R25 · FY2016 · CA
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
$462,328Antonio Fojo · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Clinical, Basic, Translational and Kinetic Studies of Drug Action and Resistance
$462,328Antonio Fojo · Division Of Clinical Sciences - Nci · ZIA · FY2012 · CA
Dual Targeting Redoxâactive Gold(I) Therapeutics
$462,195Kuppuswamy Arumugam · Wright State University · R15 · FY2018 · CA
Mechanisms that Couple Chromatin Modifications to Transcription
$462,166Karen M Arndt · University Of Pittsburgh At Pittsburgh · R35 · FY2022 · GM
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
$462,155Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Role of ETS factors in specifying prostate luminal cell identity and androgen receptor dependence
$462,155Charles L Sawyers · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Stress Induction of Glucose Regulated Protein GRP78/BiP
$462,114Amy S Lee · University Of Southern California · R01 · FY2016 · CA
MICROFLUIDIC DIAGNOSTICS FOR MONITORING OF BRAF INHIBITOR RESISTANCE IN MELANOMA
$462,107Hsian-Rong Tseng · University Of California Los Angeles · P01 · FY2014 · CA